<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Endocrine Drugs (Part A) - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>‚öõÔ∏è</span>
                        <span>Section XIII (Part A)</span>
                    </div>
                    <h1 class="document-title">Drugs Used in Endocrine Disorders</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Pituitary, Thyroid, Diabetes & Adrenal Steroids</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>90 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 63 -->
                    <section class="content-section" id="chapter-63">
                        <div class="section-header">
                            <div class="section-number">63</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß†</span>
                                Anterior Pituitary Hormones
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>The anterior pituitary secretes trophic hormones regulated by hypothalamic releasing or inhibiting factors.</p>

                            <h3>Growth Hormone (GH)</h3>
                            <p><strong>Physiological Actions:</strong> Promotes linear growth (via IGF-1), protein anabolism, lipolysis, and insulin antagonism (diabetogenic).</p>
                            <p><strong>Therapeutic Uses:</strong>
                            <br>1. <strong>Pituitary Dwarfism:</strong> Recombinant hGH (Somatropin) is used.
                            <br>2. <strong>Turner Syndrome</strong> and Chronic Renal Insufficiency in children.
                            <br>3. <strong>AIDS Cachexia:</strong> To promote anabolism.</p>

                            <h3>Drugs for Acromegaly (GH Excess)</h3>
                            <ul>
                                <li><strong>Somatostatin Analogues:</strong> <strong>Octreotide, Lanreotide</strong>. Inhibit GH release. Long-acting. Also used for carcinoid syndrome and esophageal varices.</li>
                                <li><strong>Dopamine Agonists:</strong> <strong>Bromocriptine</strong> (High dose). Less effective than octreotide.</li>
                                <li><strong>GH Receptor Antagonist:</strong> Pegvisomant.</li>
                            </ul>

                            <h3>Prolactin</h3>
                            <p>Regulated by tonic inhibition by Dopamine (PIF). Hyperprolactinemia causes galactorrhea, amenorrhea, and infertility.</p>
                            <p><strong>Drugs for Hyperprolactinemia (Dopamine Agonists):</strong>
                            <br><strong>Bromocriptine:</strong> D2 agonist. Suppresses prolactin. Also used in Parkinsonism and Acromegaly. Side effects: Nausea, postural hypotension.
                            <br><strong>Cabergoline:</strong> Long-acting D2 agonist. More effective and better tolerated. Drug of choice.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 63 -->

                    <!-- START: Chapter 64 -->
                    <section class="content-section" id="chapter-64">
                        <div class="section-header">
                            <div class="section-number">64</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü¶ã</span>
                                Thyroid Hormones and Antithyroid Drugs
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Thyroid Hormones</h3>
                            <p><strong>T4 (Thyroxine):</strong> Prohormone. Long half-life (7 days). Converted to T3 in tissues.
                            <br><strong>T3 (Triiodothyronine):</strong> Active hormone. Short half-life (1 day). Potent.</p>
                            <p><strong>Uses:</strong>
                            <br>1. <strong>Cretinism/Hypothyroidism:</strong> <strong>Levothyroxine (T4)</strong> is the drug of choice. Oral, once daily (empty stomach).
                            <br>2. <strong>Myxedema Coma:</strong> Medical emergency. IV Levothyroxine (+ IV Hydrocortisone).</p>

                            <h3>Antithyroid Drugs (For Hyperthyroidism)</h3>
                            
                            <h4>1. Thioamides</h4>
                            <p><strong>Propylthiouracil (PTU), Carbimazole, Methimazole.</strong>
                            <br><strong>Mechanism:</strong> Inhibit <strong>Thyroid Peroxidase</strong>, preventing oxidation of iodide and coupling of iodotyrosines. PTU also inhibits peripheral conversion of T4 to T3.
                            <br><strong>Adverse Effects:</strong> Skin rash, arthralgia. <strong>Agranulocytosis</strong> (rare but serious - monitor sore throat/fever).
                            <br><strong>Pregnancy:</strong> PTU is preferred in the first trimester (less teratogenic); Methimazole/Carbimazole can be used later.</p>

                            <h4>2. Iodides (Lugol's Iodine, SSKI)</h4>
                            <p><strong>Mechanism:</strong> Inhibit hormone release (Thyroid constipation) and vascularity.
                            <br><strong>Uses:</strong> Preoperative preparation (to make gland firm/less vascular), Thyroid Storm. Not for long-term use (escape phenomenon).</p>

                            <h4>3. Radioactive Iodine ($^{131}I$)</h4>
                            <p><strong>Mechanism:</strong> Emits beta rays destroying thyroid follicles. "Medical Thyroidectomy".
                            <br><strong>Uses:</strong> Graves' disease (especially elderly), Toxic nodular goiter.
                            <br><strong>Contraindication:</strong> Pregnancy, Children.
                            <br><strong>Disadvantage:</strong> Delayed Hypothyroidism (permanent).</p>

                            <h4>4. Beta Blockers (Propranolol)</h4>
                            <p>Symptomatic control (tachycardia, tremor, anxiety). Also inhibits peripheral T4 to T3 conversion (weakly).</p>

                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö°</span>
                                    <h4 class="callout-title">Thyroid Storm (Thyrotoxic Crisis) Management</h4>
                                </div>
                                <div class="callout-content">
                                    <ol>
                                        <li><strong>Propranolol:</strong> IV/Oral to control cardiac symptoms.</li>
                                        <li><strong>Propylthiouracil:</strong> High dose (blocks synthesis + conversion).</li>
                                        <li><strong>Iodides:</strong> (1 hour after PTU) to block release.</li>
                                        <li><strong>Hydrocortisone:</strong> IV (prevents shock + blocks conversion).</li>
                                        <li>Supportive care (Cooling, fluids).</li>
                                    </ol>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 64 -->

                    <!-- START: Chapter 65 -->
                    <section class="content-section" id="chapter-65">
                        <div class="section-header">
                            <div class="section-number">65</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Diabetes Mellitus: Insulin and Oral Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Insulin</h3>
                            <p><strong>Mechanism:</strong> Binds to tyrosine kinase receptors. Increases glucose entry (GLUT-4) into muscle/fat, promotes glycogen/protein/lipid synthesis.
                            <br><strong>Indications:</strong> Type 1 DM, Type 2 DM (if uncontrolled, surgery, pregnancy, stress), DKA.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Insulin Preparations</caption>
                                    <thead>
                                        <tr>
                                            <th>Type</th>
                                            <th>Examples</th>
                                            <th>Onset/Duration</th>
                                            <th>Characteristics</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Rapid Acting</strong> (Analogues)</td>
                                            <td>Lispro, Aspart, Glulisine</td>
                                            <td>10-15 min / 3-5 hr</td>
                                            <td>Inject just before meal. Less hypoglycemia.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Short Acting</strong></td>
                                            <td>Regular (Soluble)</td>
                                            <td>30-60 min / 6-8 hr</td>
                                            <td>Only type for <strong>IV use</strong> (DKA). 30 min before meal.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Intermediate</strong></td>
                                            <td>NPH (Isophane)</td>
                                            <td>2 hr / 18-24 hr</td>
                                            <td>Cloudy (Protamine). Basal insulin.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Long Acting</strong></td>
                                            <td>Glargine, Detemir, Degludec</td>
                                            <td>2-4 hr / 24+ hr</td>
                                            <td>Peakless basal coverage. Less nocturnal hypoglycemia.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Oral Antidiabetic Drugs (OADs)</h3>
                            
                            <h4>1. Biguanides (Metformin)</h4>
                            <p><strong>Drug of Choice for Type 2 DM (Obese).</strong>
                            <br><strong>Mechanism:</strong> Activates AMPK. Decreases hepatic gluconeogenesis. Increases peripheral sensitivity.
                            <br><strong>Benefits:</strong> No hypoglycemia, weight loss.
                            <br><strong>ADR:</strong> GI upset (common), Lactic acidosis (rare - avoid in renal/hepatic/cardiac failure).</p>

                            <h4>2. Sulfonylureas</h4>
                            <p><strong>Glibenclamide, Glipizide, Glimepiride.</strong>
                            <br><strong>Mechanism:</strong> Block ATP-sensitive K+ channels in beta cells $\rightarrow$ Depolarization $\rightarrow$ Ca++ influx $\rightarrow$ Insulin release (Secretagogues).
                            <br><strong>ADR:</strong> <strong>Hypoglycemia</strong> (especially long acting agents in elderly), Weight gain.</p>

                            <h4>3. Meglitinides (Glinides)</h4>
                            <p><strong>Repaglinide, Nateglinide.</strong> Rapid acting secretagogues. Take just before meals. Less hypoglycemia.</p>

                            <h4>4. Thiazolidinediones (Glitazones)</h4>
                            <p><strong>Pioglitazone.</strong>
                            <br><strong>Mechanism:</strong> PPAR-gamma agonists. Increase insulin sensitivity (adipose/muscle).
                            <br><strong>ADR:</strong> Fluid retention (avoid in CHF), weight gain, bone fractures.</p>

                            <h4>5. Alpha-Glucosidase Inhibitors</h4>
                            <p><strong>Acarbose, Voglibose.</strong>
                            <br><strong>Mechanism:</strong> Inhibit CHO digestion in gut. Reduce post-prandial glucose.
                            <br><strong>ADR:</strong> Flatulence, abdominal discomfort.</p>

                            <h4>6. DPP-4 Inhibitors (Gliptins)</h4>
                            <p><strong>Sitagliptin, Vildagliptin.</strong>
                            <br><strong>Mechanism:</strong> Inhibit breakdown of incretins (GLP-1), increasing insulin and decreasing glucagon. Weight neutral.</p>

                            <h4>7. SGLT-2 Inhibitors (Gliflozins)</h4>
                            <p><strong>Dapagliflozin, Empagliflozin.</strong>
                            <br><strong>Mechanism:</strong> Inhibit glucose reabsorption in kidney $\rightarrow$ Glycosuria.
                            <br><strong>Benefits:</strong> Weight loss, BP reduction, CV benefits.
                            <br><strong>ADR:</strong> Genital infections (UTI/Thrush).</p>

                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">üöë</span>
                                    <h4 class="callout-title">Diabetic Ketoacidosis (DKA) Management</h4>
                                </div>
                                <div class="callout-content">
                                    <ol>
                                        <li><strong>Fluids:</strong> IV Normal Saline (Critical step).</li>
                                        <li><strong>Insulin:</strong> IV Regular Insulin bolus + infusion.</li>
                                        <li><strong>Potassium:</strong> Add K+ to fluids once urine output is established (Insulin shifts K+ into cells).</li>
                                        <li><strong>Bicarbonate:</strong> Only if pH &lt; 7.0.</li>
                                        <li>Treat precipitating cause (Infection).</li>
                                    </ol>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 65 -->

                    <!-- START: Chapter 66 -->
                    <section class="content-section" id="chapter-66">
                        <div class="section-header">
                            <div class="section-number">66</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Adrenal Cortical Steroids
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Glucocorticoids (Cortisol, Prednisolone, Dexamethasone)</h3>
                            
                            <p><strong>Mechanisms:</strong>
                            <br>1. <strong>Genomic:</strong> Bind to cytoplasmic receptors, translocation to nucleus, gene transcription modulation (slow).
                            <br>2. <strong>Anti-inflammatory:</strong> Inhibit Phospholipase A2 (via Lipocortin), inhibit cytokines (IL-1, IL-6, TNF), inhibit cell migration.</p>

                            <p><strong>Pharmacological Actions:</strong>
                            <br><strong>Metabolic:</strong> Gluconeogenesis (Hyperglycemia), Protein catabolism (muscle wasting), Lipolysis (redistribution of fat - moon face, buffalo hump).
                            <br><strong>Mineralocorticoid:</strong> Na+ retention, K+ loss (less with Dexamethasone/Betamethasone).
                            <br><strong>Other:</strong> Anti-inflammatory, Immunosuppressive, Anti-vitamin D (Osteoporosis).</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Drug</th>
                                            <th>Anti-inflammatory Potency</th>
                                            <th>Na+ Retaining Potency</th>
                                            <th>Duration</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Hydrocortisone</strong></td>
                                            <td>1</td>
                                            <td>1</td>
                                            <td>Short</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Prednisolone</strong></td>
                                            <td>4</td>
                                            <td>0.8</td>
                                            <td>Intermediate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Methylprednisolone</strong></td>
                                            <td>5</td>
                                            <td>0.5</td>
                                            <td>Intermediate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Dexamethasone</strong></td>
                                            <td>25</td>
                                            <td>0</td>
                                            <td>Long</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Betamethasone</strong></td>
                                            <td>25</td>
                                            <td>0</td>
                                            <td>Long</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Adverse Effects (Cushing's Syndrome)</h3>
                            <p>Hyperglycemia, Hypertension, Osteoporosis (vertebral fractures), Peptic ulcer, Psychosis, Infection susceptibility, Growth retardation in children, Cataract, Glaucoma, HPA axis suppression.</p>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Withdrawal Protocol</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Sudden withdrawal after prolonged use causes <strong>Acute Adrenal Insufficiency</strong>. Doses must be tapered slowly. During stress (surgery/infection), dose must be increased.</p>
                                </div>
                            </div>

                            <h3>Mineralocorticoids</h3>
                            <p><strong>Aldosterone, Fludrocortisone.</strong>
                            <br>Act on distal tubule to reabsorb Na+ and excrete K+/H+.
                            <br><strong>Use:</strong> Addison's disease (Replacement), Salt-losing CAH.
                            <br><strong>Antagonist:</strong> Spironolactone (Hyperaldosteronism, CHF).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 66 -->

                
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="section-12b.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Section XII-B: Specific Chemotherapy</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>13a</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                        <a href="../index.html" class="nav-button nav-button--large">
                            <div class="nav-label">Go to</div>
                            <div class="nav-title">Index</div>
                        </a>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 81%;"></div>
                            </div>
                            <div class="progress-label">Section 13 (Part A)</div>
                        </div>
                        
                        <a href="section-13b.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section XIII (Part B): Reproductive</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>